FDA Issues New Guidance On Dose Optimization For Oncology Therapies
In January 2023, the FDA issued a new draft guidance document on optimizing the dosage of drugs and biological products for the treatment of...
Source: clinicalleader.com
Page 5 - Study Evaluating News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Study Evaluating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Study Evaluating Today - Breaking & Trending Today
Kinnate Biopharma Inc. to Present Trials in Progress Poster for its Pan-FGFR Inhibitor, KIN-3248, at the 2023 ASCO Gastrointestinal Cancers Symposium and ASCO Genitourinary Cancers Symposium
17.01.2023 - SAN FRANCISCO and SAN DIEGO, Jan. 17, 2023 (GLOBE NEWSWIRE) - Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision oncology company, today announced the poster presentation of the design and rationale of a Phase 1 ... Seite 1
Source: wallstreet-online.de
New TREMFYA® (guselkumab) Post-Hoc Analysis Reveals Active Psoriatic Arthritis Patients With Early Efficacy Had Meaningful Long-Term Improvement in Health-Related Quality of Life
Post-hoc analysis of DISCOVER-2 Phase 3 data suggest active psoriatic arthritis patients with week 8 response to TREMFYA showed meaningful improvements in...
Source: prnewswire.com
DelveInsight Business Research, LLP: Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight
The rapid spread of influenza virus worldwide is driving the demand for the development of efficient influenza vaccine. Increasing clinical trials for new product development by market players
Source: finanznachrichten.de
Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight
/PRNewswire/ -- DelveInsight's 'Influenza Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline influenza...
Source: prnewswire.com